(ACAD) Acadia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Acadia Pharmaceuticals | (ACAD) share price targets
Complete technical analysis of Acadia Pharmaceuticals (ACAD) by charts plus indicators, forecast predictions and share price targets for Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-20 View latest technical analysis
10 day averaged volume of Acadia Pharmaceuticals is 2535810
Date | Daily Closing Price | Open | High | Low | Volume |
20 Tue Aug 2024 | 15.57 | 15.66 | 15.84 | 15.52 | 0.436 times |
19 Mon Aug 2024 | 15.76 | 15.28 | 15.78 | 15.28 | 0.549 times |
16 Fri Aug 2024 | 15.40 | 15.33 | 15.60 | 15.21 | 0.429 times |
15 Thu Aug 2024 | 15.40 | 15.46 | 15.54 | 15.14 | 0.652 times |
14 Wed Aug 2024 | 15.14 | 15.74 | 15.83 | 15.13 | 0.506 times |
13 Tue Aug 2024 | 15.73 | 15.33 | 16.00 | 15.28 | 0.583 times |
12 Mon Aug 2024 | 15.29 | 15.59 | 15.68 | 15.18 | 0.755 times |
09 Fri Aug 2024 | 15.63 | 15.65 | 16.00 | 15.36 | 1.513 times |
08 Thu Aug 2024 | 15.72 | 15.31 | 15.84 | 15.18 | 0.976 times |
07 Wed Aug 2024 | 15.17 | 15.40 | 16.05 | 15.08 | 2.805 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 15.5 as stoploss in an intra day buy trade for a target of 17.12. However, stock will show a bearish move below 15.5.
Share price targets for Acadia Pharmaceuticals (ACAD)
Target Type | Value |
Downside Target | 14.55 |
Downside Target | 15.08 |
Upside Target | 15.84 |
Upside Target | 16.53 |
Upside Target | 17.58 |
Upside Target | 17.85 |
Upside Target | 18.63 |
Upside Target | 18.96 |
Upside Target | 19.21 |
Upside Target | 19.42 |
Upside Target | 19.44 |
Intraday share price targets for Acadia Pharmaceuticals (ACAD)
Target Type | Value |
Downside Intraday Target | 15.29 |
Downside Intraday Target | 15 |
Upside Intraday Target | 15.85 |
Upside Intraday Target | 16.12 |
Downside Intraday Target | 15.56 |
Weekly technical analysis of Acadia Pharmaceuticals (ACAD)
Date | Weekly Closing Price | Open | High | Low | Volume |
20 Tue Aug 2024 | 15.57 | 15.28 | 15.84 | 15.28 | 0.337 times |
16 Fri Aug 2024 | 15.40 | 15.59 | 16.00 | 15.13 | 0.399 times |
09 Fri Aug 2024 | 15.63 | 17.92 | 18.96 | 15.08 | 2.288 times |
02 Fri Aug 2024 | 18.77 | 19.12 | 19.44 | 17.85 | 0.782 times |
26 Fri Jul 2024 | 19.14 | 17.88 | 19.21 | 17.79 | 0.89 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Acadia Pharmaceuticals (ACAD)
Date | Monthly Closing Price | Open | High | Low | Volume |
20 Tue Aug 2024 | 15.57 | 19.08 | 19.42 | 15.08 | 0.818 times |
31 Wed Jul 2024 | 19.02 | 16.19 | 19.44 | 15.40 | 1.2 times |
28 Fri Jun 2024 | 16.25 | 15.12 | 16.53 | 14.55 | 0.814 times |
31 Fri May 2024 | 15.10 | 16.84 | 17.58 | 14.60 | 1.289 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Acadia Pharmaceuticals (ACAD)
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Acadia Pharmaceuticals in short term and the sell signal is strong.
Acadia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Acadia Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 15.43 and Acadia Pharmaceuticals (ACAD) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Acadia Pharmaceuticals in short term and the sell signal is strong.
Acadia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Acadia Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 15.43 and Acadia Pharmaceuticals (ACAD) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.